Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Rouen Cedex, France Clinical Trials

A listing of Rouen Cedex, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (7) clinical trials

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

Chronic plaque psoriasis is the most common form of psoriatic skin disease; however, there is growing evidence that other variants including scalp, nail, inverse, and palmoplantar psoriasis are prevalent, undertreated, and are correlated with an increased risk of psoriatic arthritis that may result in significant morbidity with functional impairment and ...

Phase

0.0 miles

Learn More »

Molecular Profiling of Advanced Soft-tissue Sarcomas

Screening phase: archival frozen tumor sample and blood sample will be used for genetic profiling. Patients can be considered as pre-eligible for the randomized phase when all genetic material have been received by the Platform. Randomization phase: the randomization will allocate the following arms with a ratio 1:1: experimental Arm ...

Phase

0.0 miles

Learn More »

Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical Treatment

During rectal or complex digestive surgery with multiple digestive resections and anastomosis, the creation of enterostomy is a common procedure. In France, it is estimated that 20000 patients have an ileostomy and 16000 new digestive stomas are formed each year with approximately 30% of enterostomy. Enterostomy might sometimes give high-output ...

Phase

0.0 miles

Learn More »

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere in the Treatment of Hepatocellular Carcinoma (HCC)

TheraSphere is a radioembolic therapeutic device used in the treatment of liver cancers. The goal of the registry study is to collect prospectively: participant description, treatment goal, treatment description, treatment results, safety, quality of life and survival data to ultimately demonstrate that TheraSphere treatment meets the claims that led to ...

Phase N/A

0.0 miles

Learn More »

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

The study is to evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Interferon-beta-1a (Avonex), once a week intramuscularly in participants with RMS.

Phase

0.0 miles

Learn More »

Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer

Methodology Patient screened wil be randomized 2:1 between 2 arms: Experimental arm: Nivolumab 2 infusions (2 weeks part) before standard of care chemoradiation for 7 weeks with cisplatin at week 1, 4, and 7 Control arm: Standard of care chemoradiation for 7 weeks with cisplatin at week 1, 4, and ...

Phase

0.33 miles

Learn More »

Lenalidomide Monotherapy in R/R DLBCL

Tafasitamab (MOR00208) is currently in development for the treatment of R/R DLBCL. An ongoing, single-arm, phase II, open label, multicenter study (MOR208C203) is evaluating the efficacy and safety of tafasitamab combined with lenalidomide in patients with R/R DLBCL. In order to establish a lenalidomide monotherapy as a control cohort, this ...

Phase N/A

0.33 miles

Learn More »